XTL Biopharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOKED ISRAEL LTD | 02/14/2025 | 198,888 | $403,000 | 0.00% | 0.04% |
| MORGAN STANLEY | 02/14/2025 | 18,351 | $37,175 | -30.62% | 0.00% |
| RHUMBLINE ADVISERS | 01/30/2025 | 10,954 | $22,564 | 68.03% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
XTL Biopharmaceuticals Ltd. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of XTL Biopharmaceuticals Ltd.. The most heavily invested institutionals were:
Noked Israel Ltd: 198,888
MORGAN STANLEY: 18,351
RHUMBLINE ADVISERS: 10,954
Noked Capital LTD: 198,888
0.04% of XTL Biopharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 427,081 shares in the last 24 months. This purchase volume represents approximately $495,414 in transactions.